期刊文献+

磷酸化mTOR及其下游分子4EBP1和S6K1在浸润性乳腺癌细胞中的定位表达研究 被引量:6

On the location of phosphorelated mTOR and its downstream molecular 4EBP1 and S6K1 in invasive breast cancer cell
下载PDF
导出
摘要 目的研究磷酸化mTOR及其下游分子4EBP1和S6K1在浸润性乳腺癌细胞中的表达部位。方法随机选取于2005年3月—2009年9月就诊于新疆医科大学附属肿瘤医院的285例乳腺癌患者,挑选乳腺癌组织及癌旁组织蜡块,重新切片,使用免疫组化方法检测磷酸化mTOR及其下游分子4EBP1和S6K1在细胞中的表达部位。结果在285例癌组织切片中,p-mTOR、p-4EBP1和p-S6K1的染色阳性例数分别为279例、161例和226例;在285例癌旁组织切片中,p-mTOR、p-4EBP1和p-S6K1的染色阳性例数分别为239例、81例和136例。p-mTOR在癌组织中表达定位于细胞核有1例,细胞浆有270例,核浆共表达有8例,在癌旁组织中表达定位于细胞核有0例,细胞浆有234例,核浆共表达有5例,癌组织与癌旁组织差异未见明显统计学意义(P=0.554);p-4EBP1在癌组织中表达定位于细胞核有3例,细胞浆有45例,核浆共表达有113例,在癌旁组织中表达定位于细胞核有1例,细胞浆有6例,核浆共表达有74例,癌组织与癌旁组织差异有统计学意义(P=0.001);pS6K1在癌组织中表达定位于细胞核有3例,细胞浆有28例,核浆共表达有195例,在癌旁组织中表达定位于细胞核有6例,细胞浆有0例,核浆共表达有130例,癌组织与癌旁组织差异有统计学意义(P=0.000)。结论mTOR信号通路中磷酸化4EBP1和S6K1在浸润性乳腺癌细胞浆中表达增高与乳腺癌相关。 Objective To investigate the location of phosphorelated mTOR and its downstream molecular 4EBP1 and S6K1 in invasive breast cancer cell.Methods 285 cases of breast cancer patients were randomly selected from March,2005 to September,2009 in the affiliated Tumor Hospital of Xinjiang Medical Uni-versity.The stored paraffin blocks of cancer and pericarcinomatous tissue were selected and recut into slices.Then P-mTOR, p-4EBP1 and p-S6K1 were detected by immunohistochemistry.Result The positive staining cases of p-mTOR,p-4EBP1 and p-S6K1 in carcinomaous tissue were 279,161 and 226,in pericarcinomatous tissue were 239,81 and 136.The cases of p-mTOR expressed in nuclear,cytoplasm,or co-expressed in nuclear and cytoplasm was 1,270 and 8 in cancerous tissue,0,234 and 5 in pericarcinoma-tous tissue,without statistically significance (P =0.554);The cases of p-4EBP1 were 3,45 and 113 in cancerous tissue,1,6 and 74 in pericarcinomatous tissue,with statistically significance (P =0.001);The cases of p-S6K1 were 3,28 and 195 in cancerous tissue,6,0 and 130 in pericarcinomatous tissue,with statistically significance (P =0.000).Conclusion Higher expression of cytoplasmic p-4EBP1 and p-S6K1 in invasive breast cancer cell may indicate the progression of breast cancer.
出处 《新疆医科大学学报》 CAS 2014年第3期280-283,共4页 Journal of Xinjiang Medical University
基金 国家自然科学基金(30960376)
关键词 p-4EBP1 p-S6K1 浸润性乳腺癌 p-4EBP1 p-S6K1 p-mTOR p-mTOR invasive breast cancer
  • 相关文献

参考文献16

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [J].CA Cancer J Clin, 2011,61:69-90.
  • 2黄哲宙,陈万青,吴春晓,郑荣寿,陈建国,杨念念,王宁,张思维,郑莹.中国女性乳腺癌的发病和死亡现况——全国32个肿瘤登记点2003—2007年资料分析报告[J].肿瘤,2012,32(6):435-439. 被引量:369
  • 3No JH ,Jeon YT, Park IA, et al. Expression of mTOR protein and its clinical significance in endometrial cancer[J]. Med Sei Monit, 2009,15 : 301-305.
  • 4Noh WC, Kim YH, Kim MS, et al. Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables[J].Breast Cancer Res Treat, 2008, 110:477-483.
  • 5Lorusso PM. Mammalian target of rapamycin as a rational therapeutic target for breast cancer treatment[J]. Oncology, 2013,84:43-56.
  • 6McAuliffe PF, Meric-Bernstam F, Mills GB, et al. Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis[J]. Clin Breast Cancer, 2010,10 (Suppl 3): S59-65.
  • 7Kim EK, Kim HA, Koh JS, et al. Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast caneer[J]. Breast Cancer Res Treat, 2011, 126:93-99.
  • 8Zhang X, Shu L, Hosoi H, et al. Predominant nuclear localization of mammalian target of rapamycin in normal and malig- nant cells in eulture[J].J Biol Chem,2002,277:28127-28134.
  • 9Rojo F, Najera L, Lirola J, et al. 4E binding protein 1, a cell signaling hallmark in breast cancer that correlates with patho- logic grade and prognosis[J].Clin Cancer Res, 2007,13 : 81-89.
  • 10Penelope K, Georgia L, Elias AE, et al. Phosphorylated 4E- Binding Protein (p-4EBP1) : a novel prognostic marker in human astrocytomas[J]. Histopathology, 2012,61 : 293-305.

二级参考文献7

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:279
  • 2全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.中国肿瘤死亡报告-全国第三次死因回顾抽样调查[M].北京:人民卫生出版社,2010,6.
  • 3STEWART B W, KLEIHUES P. World Cancer Report[M]. Lyon: IARC Press, 2003: 188-193.
  • 4FERLAY J, SHIN H R, BRAY F, et al. GLOBOCAN 2008 vl. 2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [DB/OL]. Lyon: International Agency for Research on Cancer, 201 012012-02-01]. http: //globocan. iarc. fr.
  • 5全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.2010中国肿瘤登记年报(中国肿瘤登记地区2007年肿瘤发病死亡)[M].北京:军事医学科学出版社,2011:1-14.
  • 6朱晓灵,戴弘季,郝希山,陈可欣.乳腺癌筛查卫生经济学研究进展[J].肿瘤,2010,30(12):1069-1073. 被引量:17
  • 7郑莹,吴春晓,吴凡.中国女性乳腺癌死亡现况和发展趋势[J].中华预防医学杂志,2011,45(2):150-154. 被引量:180

共引文献368

同被引文献34

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部